Michelle Boyd

Dr. Boyd's responsibilities include supporting search and evaluation, nonclinical development strategy, ideation and execution of research studies to advance nonclinical therapy development. Prior to joining Cerebral Therapeutics, she held research positions at Northern Biomedical Research Inc. conducting direct to CNS drug delivery nonclinical studies and at the Michigan State University In Vivo Facility conducting efficacy and early safety testing studies.

Dr. Boyd holds a B.S. in Neuroscience from Michigan State University and a Ph.D. in Pharmaceutical Science from the University of Wisconsin-Madison.